MX2013011266A - Sal de acido benzoico de otamixaban. - Google Patents
Sal de acido benzoico de otamixaban.Info
- Publication number
- MX2013011266A MX2013011266A MX2013011266A MX2013011266A MX2013011266A MX 2013011266 A MX2013011266 A MX 2013011266A MX 2013011266 A MX2013011266 A MX 2013011266A MX 2013011266 A MX2013011266 A MX 2013011266A MX 2013011266 A MX2013011266 A MX 2013011266A
- Authority
- MX
- Mexico
- Prior art keywords
- benzoic acid
- acid salt
- amino
- methyl
- otamixaban
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se relaciona con una sal de ácido benzoico de (2R, 3R)-2-{3-[amino(imino)metil]bencil}-3-{[4-(1-oxidopiridin-4-iI)be nzoil]amino}butanoato de metilo, y con una sal de ácido benzoico de (2R,3R)-2-{3-[amino(imino)metil]bencil}-3-{[4-(1-oxidopiridin-4 -il)benzoil]amino)butanoato de metilo que está en una forma cristalina o en por lo menos una forma parcialmente cristalina, así como con los procesos para su preparación, con los métodos para usar tal sal para tratar a los sujetos que sufren de condiciones que se pueden aliviar por la administración de un inhibidor del factor Xa.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305348 | 2011-03-29 | ||
| US201161500342P | 2011-06-23 | 2011-06-23 | |
| PCT/EP2012/055364 WO2012130821A1 (en) | 2011-03-29 | 2012-03-27 | Benzoic acid salt of otamixaban |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013011266A true MX2013011266A (es) | 2014-03-27 |
Family
ID=44065390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013011266A MX2013011266A (es) | 2011-03-29 | 2012-03-27 | Sal de acido benzoico de otamixaban. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8993602B2 (es) |
| EP (1) | EP2691371B1 (es) |
| JP (1) | JP5959617B2 (es) |
| KR (1) | KR101852226B1 (es) |
| CN (1) | CN103562183B (es) |
| AU (1) | AU2012234325B2 (es) |
| BR (1) | BR112013025105A2 (es) |
| CA (1) | CA2830965C (es) |
| CY (1) | CY1116659T1 (es) |
| DK (1) | DK2691371T3 (es) |
| ES (1) | ES2539236T3 (es) |
| HK (1) | HK1189584A1 (es) |
| HR (1) | HRP20150613T1 (es) |
| IL (1) | IL228574A (es) |
| MX (1) | MX2013011266A (es) |
| MY (1) | MY161396A (es) |
| PL (1) | PL2691371T3 (es) |
| PT (1) | PT2691371E (es) |
| RU (1) | RU2597423C2 (es) |
| SG (1) | SG193612A1 (es) |
| SI (1) | SI2691371T1 (es) |
| WO (1) | WO2012130821A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5993933B2 (ja) | 2011-03-29 | 2016-09-14 | サノフイ | 安定性を改善したオタミキサバン製剤 |
| CN106565698B (zh) * | 2016-08-15 | 2019-03-08 | 南京帕隆材料科技有限公司 | 取代噻唑类衍生物及其制备方法和用途 |
| CN106518859B (zh) * | 2016-08-15 | 2019-01-18 | 南京帕隆材料科技有限公司 | 噻唑类衍生物及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5424334A (en) | 1991-12-19 | 1995-06-13 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
| RO117913B1 (ro) * | 1996-01-02 | 2002-09-30 | Aventis Pharmaceuticals Inc. | Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament |
| US6080767A (en) * | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| GB0108903D0 (en) * | 2000-10-05 | 2001-05-30 | Aventis Pharm Prod Inc | Novel crystalline forms of a factor Xa inhibitor |
| AU2008247435A1 (en) * | 2007-05-02 | 2008-11-13 | Portola Pharmaceuticals, Inc. | Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
| MA33455B1 (fr) | 2009-07-29 | 2012-07-03 | Sanofi Sa | Otamixaban pour le traitement de patients atteints d'infarctus du myocarde sans élévation du st ages et insuffisants renaux |
-
2012
- 2012-03-27 MX MX2013011266A patent/MX2013011266A/es active IP Right Grant
- 2012-03-27 MY MYPI2013003459A patent/MY161396A/en unknown
- 2012-03-27 RU RU2013148005/04A patent/RU2597423C2/ru not_active IP Right Cessation
- 2012-03-27 WO PCT/EP2012/055364 patent/WO2012130821A1/en active Application Filing
- 2012-03-27 PL PL12711858T patent/PL2691371T3/pl unknown
- 2012-03-27 CN CN201280026534.0A patent/CN103562183B/zh active Active
- 2012-03-27 PT PT127118586T patent/PT2691371E/pt unknown
- 2012-03-27 SG SG2013071766A patent/SG193612A1/en unknown
- 2012-03-27 SI SI201230219T patent/SI2691371T1/sl unknown
- 2012-03-27 JP JP2014501569A patent/JP5959617B2/ja active Active
- 2012-03-27 AU AU2012234325A patent/AU2012234325B2/en not_active Ceased
- 2012-03-27 CA CA2830965A patent/CA2830965C/en not_active Expired - Fee Related
- 2012-03-27 BR BR112013025105A patent/BR112013025105A2/pt not_active Application Discontinuation
- 2012-03-27 DK DK12711858.6T patent/DK2691371T3/da active
- 2012-03-27 EP EP12711858.6A patent/EP2691371B1/en active Active
- 2012-03-27 US US14/008,332 patent/US8993602B2/en active Active
- 2012-03-27 KR KR1020137028416A patent/KR101852226B1/ko active IP Right Grant
- 2012-03-27 ES ES12711858.6T patent/ES2539236T3/es active Active
-
2013
- 2013-09-29 IL IL228574A patent/IL228574A/en active IP Right Grant
-
2014
- 2014-03-17 HK HK14102611.9A patent/HK1189584A1/xx not_active IP Right Cessation
-
2015
- 2015-06-08 HR HRP20150613TT patent/HRP20150613T1/hr unknown
- 2015-06-17 CY CY20151100521T patent/CY1116659T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014509622A (ja) | 2014-04-21 |
| EP2691371A1 (en) | 2014-02-05 |
| EP2691371B1 (en) | 2015-03-18 |
| MY161396A (en) | 2017-04-14 |
| DK2691371T3 (da) | 2015-06-22 |
| CN103562183A (zh) | 2014-02-05 |
| AU2012234325B2 (en) | 2016-08-11 |
| AU2012234325A1 (en) | 2013-10-17 |
| SG193612A1 (en) | 2013-11-29 |
| KR20140022851A (ko) | 2014-02-25 |
| PL2691371T3 (pl) | 2015-08-31 |
| RU2597423C2 (ru) | 2016-09-10 |
| PT2691371E (pt) | 2015-07-20 |
| SI2691371T1 (sl) | 2015-07-31 |
| RU2013148005A (ru) | 2015-05-10 |
| IL228574A0 (en) | 2013-12-31 |
| IL228574A (en) | 2015-07-30 |
| US8993602B2 (en) | 2015-03-31 |
| HK1189584A1 (en) | 2014-06-13 |
| BR112013025105A2 (pt) | 2017-06-06 |
| KR101852226B1 (ko) | 2018-04-25 |
| CN103562183B (zh) | 2015-12-23 |
| JP5959617B2 (ja) | 2016-08-02 |
| CA2830965C (en) | 2019-04-09 |
| CA2830965A1 (en) | 2012-10-04 |
| CY1116659T1 (el) | 2017-03-15 |
| WO2012130821A1 (en) | 2012-10-04 |
| ES2539236T3 (es) | 2015-06-29 |
| US20140024684A1 (en) | 2014-01-23 |
| HRP20150613T1 (hr) | 2015-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014028589A3 (en) | 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
| IN2015DN02573A (es) | ||
| NZ704662A (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| EA201390917A1 (ru) | Дигетероарильные соединения в качестве ингибиторов vps34 | |
| EA201390934A1 (ru) | Композиции и способы модулирования fxr | |
| IN2014KN00948A (es) | ||
| MX2013005533A (es) | Derivados de acido amino-bisfenil-pentanoico sustituidos como inhibidores de nep. | |
| MX2012004311A (es) | Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes. | |
| MX2013002390A (es) | Tratamiento de infarto de miocardio usando antagonistas de tgf-beta. | |
| PH12014502567A1 (en) | Piperidine derivatives for gpr119 agonist | |
| MX342324B (es) | Formulaciones de otamixaban con estabilidad mejorada. | |
| MX340816B (es) | Compuestos que inhiben el glioblastoma y su uso. | |
| EA201490928A1 (ru) | Способы лечения острых приступов подагры | |
| MX2013011266A (es) | Sal de acido benzoico de otamixaban. | |
| BR112012020629A2 (pt) | forma cristalina, e, método para a terapia de um distúrbio | |
| MX2013003202A (es) | Inhibidores de oxadiazol de la produccion de leucotrienos. | |
| WO2012148148A3 (en) | Novel zinc azide complex and a process for preparing tetrazole derivatives using the same | |
| WO2013117503A3 (en) | Pi3k inhibitors for treating fibrotic diseases | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| EA201391586A1 (ru) | ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ | |
| MY162945A (en) | Azole derivative | |
| MX2015010434A (es) | Derivados de acido bisfenil-butanoico sustituido como inhibidores de la endopeptidasa neutra (nep), con una mayor eficacia in vivo. | |
| MX351994B (es) | Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico. | |
| WO2013054364A3 (en) | Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof | |
| WO2012164055A3 (en) | New compounds, synthesis and use thereof in the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |